OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/23/2026
Back to search
Official data from USPTO
GLAALPHA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
04/24/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/03/2024
Registration date
04/15/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/15/2025
Last transaction
04/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
FRIEDMAN, LESLEE ANN
Law office
N20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
KOWA COMPANY, LTD.
Representatives
No representative data.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationspharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of glaucoma and ocular hypertension; pharmaceutical preparations for the treatment of corneal endothelial disorder; veterinary preparationsveterinary preparations for the treatment of eye diseases and conditions; veterinary preparations for the treatment of glaucoma and ocular hypertension; veterinary preparations for the treatment of corneal endothelial disorder.
Publications
History of USPTO decisions and trademark events.
13 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/06/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/06/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/15/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/15/2025
PUBO
PUBLISHED FOR OPPOSITION
02/25/2025
NPUB
NOTICE OF PUBLICATION
02/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2025
DOCK
ASSIGNED TO EXAMINER
02/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
11/22/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/22/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/18/2024
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
11/07/2024
Continuous trademark protection
Get notified about every new filing that threatens GLAALPHA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.